BrightSpring Health Services (NASDAQ:BTSG) Reaches New 52-Week High - What's Next?

Key Points

• BrightSpring hit a new 52-week high of $44.90 on Wednesday, last trading at $44.79 on a volume of about 1.10 million shares.
• Analyst sentiment is broadly bullish — MarketBeat shows 2 Strong Buy, 14 Buy and 1 Hold with a consensus target of $45.50, and several firms have raised targets (e.g., BTIG $55, Wells Fargo $50).
• The company reported Q results with revenue up 29.3% year‑over‑year to $3.55 billion while EPS missed by $0.01; BrightSpring has a market cap of $8.81 billion and a PE of 51.72, and insiders sold 285,000 shares (~$11.7M) over the past 90 days.

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The stock traded as high as $44.90 and last traded at $44.79, with a volume of 1098950 shares changing hands. The stock had previously closed at $43.31.

Analyst Ratings Changes

A number of analysts recently weighed in on BTSG shares. Zacks Research upgraded BrightSpring Health Services from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, March 3rd. Leerink Partners reissued an "outperform" rating and set a $49.00 price target on shares of BrightSpring Health Services in a research note on Wednesday, March 18th. BTIG Research restated a "buy" rating and issued a $55.00 price objective on shares of BrightSpring Health Services in a report on Thursday, March 19th. Wells Fargo & Company increased their target price on shares of BrightSpring Health Services from $43.00 to $50.00 and gave the company an "overweight" rating in a report on Monday, March 2nd. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of BrightSpring Health Services in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, BrightSpring Health Services presently has an average rating of "Buy" and a consensus target price of $45.50.

BrightSpring Health Services Stock Performance

The company has a debt-to-equity ratio of 1.32, a current ratio of 1.57 and a quick ratio of 1.12. The stock has a market cap of $8.81 billion, a PE ratio of 51.72, a price-to-earnings-growth ratio of 0.55 and a beta of 2.30. The business has a 50 day moving average price of $40.18 and a two-hundred day moving average price of $35.52.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its earnings results on Friday, February 27th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.01). The firm had revenue of $3.55 billion during the quarter, compared to analysts' expectations of $3.38 billion. BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.The firm's quarterly revenue was up 29.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.11 earnings per share. As a group, equities research analysts forecast that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

Insider Activity

In other news, insider Lisa A. Nalley sold 30,000 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $1,234,500.00. Following the completion of the sale, the insider directly owned 110,594 shares in the company, valued at approximately $4,550,943.10. This represents a 21.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jennifer A. Phipps sold 35,000 shares of the firm's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $1,440,250.00. Following the completion of the sale, the chief financial officer directly owned 196,840 shares in the company, valued at $8,099,966. The trade was a 15.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 285,000 shares of company stock valued at $11,727,750. Insiders own 3.40% of the company's stock.

Institutional Investors Weigh In On BrightSpring Health Services

A number of large investors have recently made changes to their positions in the business. NBC Securities Inc. bought a new position in shares of BrightSpring Health Services during the fourth quarter valued at approximately $29,000. Salomon & Ludwin LLC purchased a new position in BrightSpring Health Services during the 4th quarter valued at $30,000. EverSource Wealth Advisors LLC bought a new position in BrightSpring Health Services in the 2nd quarter worth $43,000. CWM LLC raised its holdings in BrightSpring Health Services by 105.3% in the 3rd quarter. CWM LLC now owns 1,595 shares of the company's stock worth $47,000 after purchasing an additional 818 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its position in shares of BrightSpring Health Services by 112.8% in the 4th quarter. Farther Finance Advisors LLC now owns 1,717 shares of the company's stock worth $64,000 after purchasing an additional 910 shares during the period.

About BrightSpring Health Services

BrightSpring Health Services NASDAQ: BTSG is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company's operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient's home environment, fostering independence and improving quality of life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.